Fast Facts: Reference Pricing
Medicare Barriers to Cancer Diagnostics
Telemedicine: A Position Statement
COVID-19 Ushers in New Normal for Cancer Trials
Reimbursement Policy Leaves Cancer Patients in a Lurch
Can Precision Medicine Redefine Autoimmune Disease Treatment?
Medicare Part D & Out-of-Pocket Smoothing
Alliance for Patient Access
Access Issues Linger for Cancer Patients
Innovative Approaches in Patient-Centered Cancer Care
Innovation Spurs Need for Patient-Centered Cancer Care
